Clinical Trials Browser

Adenocarcinoma of Lung, Mesothelioma, Malignant, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05269355 2025-06-13

SUNRISELMS

Phase 2/3 Terminated

359 enrolled 15 charts

Sarcoma

Leiomyosarcoma

NCT04996004 2024-12-11

TTI-621-03

Phase 2 Terminated

76 enrolled 53 charts

Sarcoma

Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

NCT03670069 2024-05-08

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Phase 1 Terminated

27 enrolled

Sarcoma

Chondrosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Histiocytoma, Malignant Fibrous

NCT02940041 2023-12-26

CERTUM

Terminated

15 enrolled

Sarcoma

Disease, Leiomyoma, Leiomyosarcoma

NCT05116683 2023-12-06

ATX-101

Phase 2 Terminated

4 enrolled 12 charts

Sarcoma

Leiomyosarcoma, Liposarcoma

NCT04171700 2023-10-02

LODESTAR

Phase 2 Terminated

83 enrolled 16 charts

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinosarcoma, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Leiomyosarcoma, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03959033 2022-08-31

Patient Reported Outcome Measures (PROMs) With Trabectedin

Terminated

7 enrolled

Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT02601209 2022-08-23

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Phase 1/2 Terminated

151 enrolled 22 charts

Sarcoma

Leiomyosarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT03074318 2022-04-29

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Terminated

35 enrolled 21 charts

Sarcoma

Leiomyosarcoma, Liposarcoma

NCT04099277 2021-08-31

A Study of LY3435151 in Participants With Solid Tumors

Phase 1 Terminated

2 enrolled 8 charts

BreastGastrointestinalGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms

NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Phase 2 Terminated

3 enrolled 6 charts

GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

NCT00414076 2018-11-20

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Phase 2 Terminated

9 enrolled 7 charts

GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

NCT01418001 2018-01-11

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Phase 1/2 Terminated

5 enrolled 6 charts

Sarcoma

Leiomyosarcoma, Sarcoma, Neurofibrosarcoma, Histiocytoma, Histiocytoma, Malignant Fibrous

NCT01189253 2014-08-08

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Phase 2/3 Terminated

133 enrolled

Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT00003292 2013-11-08

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Phase 2 Terminated

7 enrolled

CNSSarcoma

Chondrosarcoma, Fibrosarcoma, Leiomyosarcoma, Meningioma, Rhabdomyosarcoma

Clinical Trials

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

SUNRISELMS

TTI-621-03

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

CERTUM

ATX-101

LODESTAR

Patient Reported Outcome Measures (PROMs) With Trabectedin

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

A Study of LY3435151 in Participants With Solid Tumors

Vorinostat (SAHA) in Uterine Sarcoma

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

S9624 Ifosfamide in Treating Patients With Meningeal Tumors